Metastatic germ cell tumor with complete response-7 years follow up

Authors

  • Branislava Golub Jakovljevic Hospital for Surgical and Internal Medicine S. tetik, Banja Luka, B and H, Republika Srpska
  • Dejan Đokanović Department of Oncology, University Clinical Centre, Banja Luka, B and H, Republika Srpska
  • Snježana Miličević Department of Urology, University Clinical Centre, Banja Luka, B and H, Republika Srpska
  • Anđa Škobić Hospital for Surgical and Internal Medicine S. tetik, Banja Luka, B and H, Republika Srpska
  • Dejan Ćazić International Medical Centers, Centre for Radiotherapy, Banja Luka, B and H, Republika Srpska
  • Vladimir Krivokuća Department of Urology, University Clinical Centre, Banja Luka, B and H, Republika Srpska

DOI:

https://doi.org/10.18203/2320-6012.ijrms20175470

Keywords:

Complete response, Germ cell tumor, Metastatic disease

Abstract

Cancer of the testis is a relatively uncommon disease, accounting for approximately 1-1.5% of all cancers in males.  5% of the malignant germ cell tumors are made of extragonadal origin. Germ cell tumors occur in men younger, usually between 20 and 35 years old. We report a case of a patient with metastatic extragonadal germ cell tumor with multiple sites of metastases, and very high initial values of tumor marker human chorionic gonadotrophin (HCG)- 1351308. At the time of diagnosis, the patient was in a very poor general condition. After the applied chemotherapy, there was a complete response and 7 years later the patient is without any symptoms of disease.

Metrics

Metrics Loading ...

References

Oldenburg J, Fosså SD, Nuver J, Heidenreich A, Schmol HJ, Bokemeyer C, et al. Testicular Seminoma and Non-Seminoma: ESMO Clinical Practice Guidelines. Ann Oncol. 2013;24(Suppl 6):vi125-vi132.

Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Møller H. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Inter J Cancer. 2006;118(12):3099-111.

Schmoll HJ, Jordan K, Huddart R, Pes ML, Horwich A, Fizazi K, Kataja V, ESMO Guidelines Working Group. Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl_5):v140-6.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: A Cancer J Clinic. 2016;66(1):7-30.

Einhorn LH, Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Inter Medic. 1977;87(3):293-8.

Huddart R, Kataja V. ESMO Guidelines Working Group. Mixed or non- seminomatous germ-cell tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19:49-51.

Feldman DR, Bosl GJ, Sheinfeld J, Motzer RJ. Medical treatment of advanced testicular cancer. JAMA. 2008;299:672-684.

Schmoll HJ. Extragonadal germ cell tumors. Annals of Oncology. 2002;13(suppl_4):265-72.

Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Euro Urol. 2008;53(3):478-96.

Bokemeyer C, Nowak P, Haupt A, Metzner B, Köhne H, Hartmann JT, Kanz L, Schmoll HJ. Treatment of brain metastases in patients with testicular cancer. J Clinic Oncol. 1997;15(4):1449-54.

Hartmann JT, Fossa SD, Nichols CR, Droz JP, Horwich A, Gerl A, et al. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. J Nation Can Insti. 2001;93(22):1733-8.

Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, et al. The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors. Cancer. 2000;88(11):2629-35.

Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, et al. Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Nation Can Insti. 2000;92(1):54-61.

Downloads

Published

2017-11-25

How to Cite

Jakovljevic, B. G., Đokanović, D., Miličević, S., Škobić, A., Ćazić, D., & Krivokuća, V. (2017). Metastatic germ cell tumor with complete response-7 years follow up. International Journal of Research in Medical Sciences, 5(12), 5443–5446. https://doi.org/10.18203/2320-6012.ijrms20175470

Issue

Section

Case Reports